From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Downloadable slides on individualizing perioperative treatment for patients with high-risk HR-positive and/or germline BRCA–mutated early-stage breast cancer.

Jennifer K. Litton, MD Released: June 3, 2022

Downloadable slides on leveraging immune checkpoint inhibitors for perioperative treatment of patients with early-stage triple-negative breast cancer.

Rita Nanda, MD Released: June 3, 2022

Downloadable slides featuring expert perspectives on clinical challenges and controversies in the rapidly evolving management of early-stage breast cancer.

Heather McArthur, MD, MPH Released: June 3, 2022

In this on-demand webcast from a live symposium, experts Heather McArthur, MD, MPH; Jennifer K. Litton, MD; and Rita Nanda, MD discuss the most up-to-date guidance on managing early-stage breast cancer.

Heather McArthur, MD, MPH
Program Director Jennifer K. Litton, MD Rita Nanda, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: June 8, 2022 Expired: No longer available for credit

Management of early-stage breast cancer is rapidly evolving with perioperative options now including abemaciclib, olaparib, and pembrolizumab. In this commentary, Heather McArthur, MD, MPH, shares key takeaways on the latest developments.

Heather McArthur, MD, MPH
Program Director Released: August 4, 2022